Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

inTest Corporation Common Stock (NY:INTT)

6.000 +0.140 (+2.39%)
Official Closing Price Updated: 8:00 PM EDT, Apr 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about inTest Corporation Common Stock

< Previous 1 2 3 4 5 6 Next >
inTEST Reports $29.8 Million in Revenue for First Quarter 2024
From inTEST Corporation
Via Business Wire
inTEST Extends Maturity Date of Borrowing Agreement to 2031
From inTEST Corporation
Via Business Wire
inTEST Corporation Launches Leading-Edge Benchtop Temperature Test System
From inTEST Corporation
Via Business Wire
Recap: inTest Q4 Earnings
Via Benzinga
Earnings Outlook For inTest
Via Benzinga
Preview: inTest's Earnings
Via Benzinga
What Is the Best $10 Stock to Buy in April? 3 Top Picks
Despite the headwinds, the best $10 stocks could shine as inflation targets come within reach, hinting at an upcoming bull run. 
Via InvestorPlace
Topics Economy
Exposures Interest Rates
inTEST Schedules First Quarter 2024 Financial Results Conference Call and Webcast
From inTEST Corporation
Via Business Wire
inTEST Corporation to Present at the LD Micro Invitational Conference
From inTEST Corporation
Via Business Wire
INTT Stock Earnings: inTest Beats EPS, Misses Revenue for Q4 2023
INTT stock results show that inTest beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023. 
Via InvestorPlace
inTEST Reports Record $123.3 Million in Revenue and Net Income of $9.3 Million for Full Year 2023
From inTEST Corporation
Via Business Wire
inTEST Announces Fourth Quarter and Full Year 2023 Financial Results Conference Call and Webcast
From inTEST Corporation
Via Business Wire
inTEST Expands Electronic Test Capabilities with Acquisition of Alfamation S.p.A.
From inTEST Corporation
Via Business Wire
inTEST to Restate Third Quarter and First Nine Months 2023 Financial Statements
From inTEST Corporation
Via Business Wire
The 7 Most Deeply Undervalued Stocks on Wall Street Right Now
With the stock market at a junction, now is the time to invest in deeply undervalued stocks before a new bull market lifts them higher. 
Via InvestorPlace
12 Information Technology Stocks Moving In Monday's After-Market Session
Via Benzinga
inTEST Delays Fourth Quarter and Full Year 2023 Earnings Release and Investor Conference Call; Provides Preliminary Fourth Quarter Results and 2024 Guidance
From inTEST Corporation
Via Business Wire
inTEST Announces Fourth Quarter and Full Year 2023 Financial Results Conference Call and Webcast
From inTEST Corporation
Via Business Wire
inTEST Appoints Michael Goodrich as President, Process Technologies Division
From inTEST Corporation
Via Business Wire
7 Compelling Tech Stocks to Snag From the Discount Bin
Although the innovation ecosystem saw gargantuan returns, investors can still find compelling discount tech stocks. 
Via InvestorPlace
inTEST Corporation Launches Next Generation of Induction Heating Systems
From inTEST Corporation
Via Business Wire
12 Information Technology Stocks Moving In Tuesday's After-Market Session
Via Benzinga
inTEST Continues Executing on Five-Point Strategy to Expand Geographically - Establishes Southeast Asia Center of Excellence in Malaysia
From inTEST Corporation
Via Business Wire
inTEST Corporation to Participate in the 12th Annual NYC Summit
From inTEST Corporation
Via Business Wire
inTEST Corporation Announces Stock Repurchase Plan
From inTEST Corporation
Via Business Wire
inTEST Corporation to Webcast Presentation at the Southwest IDEAS Conference
From inTEST Corporation
Via Business Wire
Earnings Scheduled For November 3, 2023
Companies Reporting Before The Bell • Arcutis Biotherapeutics (NASDAQ:ARQT) is expected to report quarterly loss at $0.86 per share on revenue of $32.83 million. 
Via Benzinga
inTEST Reports Record $32.7 Million in Revenue for the 2023 Third Quarter with Earnings per Diluted Share up 4% to $0.24 Year-over-Year
From inTEST Corporation
Via Business Wire
7 Undervalued Stocks That Analysts Love Right Now
With many investors concerned about what may lie ahead in the market, these potentially de-risked undervalued stocks may be ideal. 
Via InvestorPlace
inTEST Announces Third Quarter 2023 Financial Results Conference Call and Webcast on November 3
From inTEST Corporation
Via Business Wire
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.